We have recently demonstrated that Klf15 expression is significantly downregulated in muscle of presymptomatic SMA mice and that upregulating Klf15 expression via genetic (transgenic muscle-specific expression) or pharmacological (prednisolone) approaches results in improved disease phenotypes [18]. Here, KLF15 is linked to proximal spinal muscular atrophy.